Twist Bioscience Corporation (TWST) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Twist Bioscience Corporation  (NASDAQ: TWST)


Twist Bioscience's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Twist Bioscience's ROI in the third quarter of 2026?
Twist Bioscience Corporation recorded a cumulative net loss of $-137 million during 12 months ending in the third quarter of 2026, resulting in a negative return on investment (ROI) of -24.75%.

Within the Healthcare sector 343 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 3178 to 3217.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
III. Quarter
(Mar 31 2026)
II. Quarter
(Dec 31 2025)
I. Quarter
(Sep 30 2025)
IV. Quarter
(Jun 30 2025)
III. Quarter
Y / Y Investment Change TTM 2.1 % 1.94 % -4.74 % -11.25 % -16.96 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 552 556 550 550 557
Return On Investment (TTM) -24.75 % -14.69 % -14.06 % -14.31 % -15.75 %
TWST's Overall Ranking # 3217 # 3178 # 436 # 2779 # 2920
Seq. Investment Change TTM -0.2 % 1.63 % 0.33 % 0.33 % -0.36 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -137 -81 -77 -78 -85




Return On Investment TWST's Ranking
Within: No.
Industry # 38
Sector # 344
Overall # 3217

Return On Investment Statistics
High Average Low
-14.06 %
-34.69 %
-91.31 %
(Dec 31 2025)   (Dec 31 2019)



  News about Twist Bioscience Corporation Return on Investment ROI

Twist Bioscience Secures Financial Wizard Adam Laponis as CFO, Fueling Growth and Innovation in Synthetic DNA

January 5, 2024

Twist Bioscience Welcomes Adam Laponis as New CFO, Boosting Financial Expertise and Strategic Planning for Future Growth
SOUTH SAN FRANCISCO, Calif. - Twist Bioscience Corporation (NASDAQ: TWST) has recently announced the appointment of Adam Laponis as their chief financial officer. This move signifies another significant milestone for the company, further solidifying its commitment to delivering high-quality synthetic DNA through its innovative silicon platform.
Mr. Laponis brings with him a wealth of experience working across diverse industries, ranging from small-cap to Fortune 50 companies. He has a proven knack for driving profitable growth through strategic financial planning and fostering collaboration within teams. His deep financial acumen makes him an excellent addition to the Twist Bioscience leadership team.






Financial Statements
Twist Bioscience's III. Quarter Investments $ 552 Millions TWST's Balance sheet
Twist Bioscience's III. Quarter Income $ -35 Millions Quarterly TWST's Income Statement
TWST's Income by Division See TWST's Income by Division


TWST Annual Return On Investment (Sep 30 2025)
2025
(Sep 30 2024)
2024
(Sep 30 2023)
2023
(Sep 30 2022)
2022
(Sep 30 2021)
2021
Total Investments in Millions 550 543 703 871 639
Y / Y Investment Growth 1.31 % -22.72 % -19.25 % 36.25 % 85.02 %
Net Income in Millions -78 -209 -205 -218 -152
Y / Y Net Income Growth - - - - -
Annual Return On Investment -14.11 % -38.42 % -29.1 % -25.02 % -23.8 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TWST's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TWST's Competitors
Subscribers only: Roi for Twist Bioscience's Suppliers
Subscribers only: Return On Investment for TWST's Customers

Other Ratios
TWST's Roa TWST's Inventory Turnover Ratio TWST's Growth Rates TWST's Dividend Statistics
TWST's Profitability Ratios TWST's Asset Turnover Ratio TWST's Dividend Growth
TWST's Roe TWST's Valuation Ratios TWST's Financial Strength Ratios TWST's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI


Date modified: 2026-09-13T23:42:31+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.